Louise Maymann Nitze

Author

Novo Nordisk (Denmark)

Also Known As

L. Nitze, LM Nitze, Louise M Nitze, Louise M. Nitze, Louise Maymann Nitze

Publications

241

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)NIHR Newcastle Biomedical Research Centre Newcastle University Inserm Chinese University of Hong Kong

About

Louise Maymann Nitze is an author at Novo Nordisk (Denmark) specializing in breast cancer, proteomics, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	35
2	Cell Biology	1	1	35
3	Tumor Biology	1	1	35
4	Breast Cancer	1	1	35
5	Cancer Research	1	1	35

Louise Maymann Nitze

Publications

240

Citations

H-Index

Page 1

	Year	Citations
Prognostic utility of Fibrosis-4 Index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and/or type 2 diabetes: a longitudinal cohort study Quentin M. Anstee, Tina Landsvig Berentzen, Louise Maymann Nitze, The Lancet Regional Health - Europe	2023	94
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer Louise Maymann Nitze, Elisabeth D. Galsgaard, Nanni Din, Breast Cancer Research and Treatment Pituitary Hormone ProlactinBreast OncologyPrl ExpressionMedicineMammary Gland	2013	35
Collagen Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through Osteoclast-Associated Receptor Heidi S. Schultz, Louise Maymann Nitze, Louise Zeuthen, The Journal of Immunology	2015	35
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis Maximilian Jara, Jenny Norlin, Mette Skalshøi Kjær, Nature Medicine	2025	30
FibroScan-aspartate aminotransferase (FAST) score for monitoring histological improvement in non-alcoholic steatohepatitis activity during semaglutide treatment: post-hoc analysis of a randomised, double-blind, placebo-controlled, phase 2b trial Vincent Wai‐Sun Wong, Quentin M. Anstee, Louise Maymann Nitze, EClinicalMedicine	2023	29
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction–associated steatohepatitis Zobair M. Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Hepatology Communications	2024	17

Page 1